This agenda is from the 2018 show. The 2019 agenda is to be announced closer to the show.
Wednesday 6th June
Thursday 7th June
11.00 - 11.30
The use of radiopharmaceuticals in cancer treatment is growing rapidly, with many new radiotherapeutics either in development or going through early-phase trials. Molecular radiotherapy and theragnostics promise to offer significant advances in cancer care, and the market expected to grow by 30% per annum for the foreseeable future. Glenn's presentation will review the potential impact of this expansion for industry, academia, and patients.
11.45 - 12.15
Sanjay P Prabhu
Sanjay discusses the role of machine learning in the acquisition and interpretation of imaging studies performed in children with brain tumours. Topics explored will include areas where tumour imaging is best interpreted by a machine; situations where a machine can put together information from multiple sources and inform the radiologist to make a better interpretation; and the role of machine learning in correlating imaging findings to the genetic make up of the tumour and treatment options.
12.30 - 13.00
Mylaine's seminar will highlight old and emerging worldwide data that points to metabolic causes of cancer, and not just genetics (as is the current focus). She'll discuss how a metabolic causation theory explains not only the reason we get cancer, but offers strategies to treat it and prevent recurrences from a more root cause - a method that incorporates allopathic and integrative strategies.
13.15 - 13.45
Perspective overview from University College London Hospitals NHS Foundation Trust of implementing the NHS high energy proton therapy service with the Christie NHS Foundation Trust.
14.00 - 14.30
FStereotactic body radiotherapy (SBRT) provides a highly focused radiation technique allowing delivery of radiation doses far higher than previously thought possible without compromising normal tissue. This technique is especially useful in medically-inoperable patients. Merina specialises in SBRT for lung cancer and oligometastatic cancers. She'll talk about the application of this technique and the expected outcomes. Future directions on the use of SBRT will also be discussed.
15.30 - 16.00
This seminar will explore current advances in surgical techniques and technology that can enhance the extent of resection in Low Grade Gliomas, such as Awake Craniotomy and Intraoperative Neurophysiological Monitoring. The seminar will also explore the role of Functional MRI Imaging and Neuro-navigation, as well as Intraoperative MRI and Ultrasound, in achieving maximal safe resection.